Product Details
TREVICTA 175mg prolonged release suspension for injection#
Paliperidone palmitate175mg
Suspension for injection
ROA
Intramuscular
Applicant Name
J & J Company West Africa Limited
NRN
A4-100554
Status
Active
Composition
ATC Code
N05AX13
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 X 1
Product Description
49 NF-PP-268978 TREVICTA 175mg prolonged release suspension for injection Paliperidone palmitate Each prefilled syringe contains 273 mg paliperidone palmitate equivalent to 175 mg paliperidone. Excipients include Polysorbate 20 Polyethylene glycol 4000 Citric acid monohydrate Sodium dihydrogen phosphate monohydrate Sodium hydroxide (for pH adjustment) Water for injections A4-100554 Drugs Imported Products 1*1 Prescription Only Medicine (POM) 7/17/2023 J & J COMPANY WEST AFRICA LIMITED, SINARI DARANIJO STREET, VICTORIA ISLAND LAGOS LAGOS 9062881239 uugwulek@its.jnj.com JANSSEN PHARMACEUTICA N.V, TURNHOUTSEWEG 30, B-2340 BEERSE, BELGIUM, Belgium
Manufacturer Name
Janssen Pharmaceutica NV
Manufacturer Country
BELGIUM
Approval Date
2023-10-31
Expiry Date
2028-10-30